USP's draft model formulary raises questions about guidelines

Although The U.S. Pharmacopeia's (USP) interim Medicare Prescription Drug Benefit Draft Model Guidelines recommend a drug classification system, CMS will consider other alternatives as long as the formularies provide preferred access to a broad range of widely used drugs.